Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Reference Standard Qualification for AMD – V 2.0

Posted on By

Analytical Method Development: Reference Standard Qualification for AMD – V 2.0

SOP for Qualification of Reference Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/021/2025
Supersedes SOP/AMD/021/2022
Page No. Page 1 of 15
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for qualification, documentation, storage, and usage of reference standards in the Analytical Method Development (AMD) department to ensure accuracy, traceability, and compliance with applicable regulatory requirements including

ICH Q6A, WHO TRS, and pharmacopeial standards.

2. Scope

This SOP applies to all primary, secondary, and working reference standards procured, qualified, and used within the AMD department for analytical method development, method validation, and routine analysis.

3. Responsibilities

  • Analytical Scientist: Performs testing required for qualification and documents certificate of analysis (CoA).
  • QA: Verifies qualification data and authorizes reference standard usage.
  • Store Personnel: Ensures proper labeling, storage, and inventory of qualified standards.
  • Head – AMD: Approves qualification reports and oversees compliance.
See also  Analytical Method Development: Change Control for Developed Methods - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that only appropriately qualified and approved reference standards are used in all analytical procedures.

5. Procedure

5.1 Classification of Reference Standards

  1. Primary Standard: Official standard substance obtained from pharmacopeial sources (e.g., USP, EP, IP).
  2. Secondary Standard: In-house standard qualified against a primary standard.
  3. Working Standard: Prepared from secondary or primary standard for routine use.

5.2 Procurement and Receipt

  1. Obtain primary standards from certified suppliers (e.g., USP, EDQM, NIB).
  2. Upon receipt, record details in Annexure-1: Reference Standard Receipt Log.
  3. Assign a unique identification code (e.g., RS/2025/001).

5.3 Qualification of Secondary/Working Standards

  1. Weigh and prepare standard solution from candidate material.
  2. Analyze against certified primary standard using validated method.
  3. Perform at least 3 replicates and calculate assay %.
  4. Acceptance Criteria: Assay between 98.0–102.0% of label claim with %RSD ≤ 2.0%.
  5. Document all results in Annexure-2: Reference Standard Qualification Form.
See also  Analytical Method Development: Method Lifecycle Management - V 2.0

5.4 Documentation and Approval

  1. Prepare Certificate of Analysis (CoA) including:
    • Source and batch no.
    • Physical appearance
    • Water content (if applicable)
    • Assay % and assigned purity
    • Shelf-life
  2. Review by QA and approval by Head – AMD.
  3. Archive signed CoA in Annexure-3: Reference Standard CoA Register.

5.5 Storage and Labeling

  1. Label containers with:
    • Name
    • Code
    • Purity %
    • Date of Qualification
    • Expiry Date
    • Storage Condition
  2. Store in desiccator or as per CoA requirements.
  3. Maintain Annexure-4: Reference Standard Usage Log.

5.6 Requalification and Expiry

  1. Requalification to be done:
    • Every 12 months (if no stability data available)
    • Or as per shelf-life assigned in CoA
  2. Destroy expired standards using QA-approved procedure.

6. Abbreviations

  • AMD: Analytical Method Development
  • RS: Reference Standard
  • CoA: Certificate of Analysis
  • USP: United States Pharmacopeia
  • EP: European Pharmacopoeia
  • NIB: National Institute of Biologicals

7. Documents

  1. Reference Standard Receipt Log – Annexure-1
  2. Reference Standard Qualification Form – Annexure-2
  3. Reference Standard CoA Register – Annexure-3
  4. Reference Standard Usage Log – Annexure-4

See also  Analytical Method Development: Analytical Target Profile (ATP) Documentation - V 2.0

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • WHO TRS 996 – Annex 3
  • USP General Chapter <11> – Reference Standards
  • Ph. Eur. Chapter 5.12 – Qualification of Reference Standards

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Reference Standard Receipt Log

RS Code Name Batch No. Supplier Received Date
RS/2025/001 Amlodipine Besylate AB12345 USP 02/05/2025

Annexure-2: Reference Standard Qualification Form

Sample Primary Std. Ref Assay (%) RSD (%) Qualified?
RS/2025/002 USP AB12345 99.2 1.2 Yes

Annexure-3: Reference Standard CoA Register

RS Code Purity Qualified On Expiry Date Approved By
RS/2025/002 99.2% 04/05/2025 04/05/2026 QA Head

Annexure-4: Reference Standard Usage Log

Date Analyst Purpose Quantity Used Balance
06/05/2025 Sunita Reddy Assay Development 10 mg 90 mg

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added annexures and clarified requalification timelines Regulatory harmonization
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Prevention of Cross Contamination during Drying – V 2.0
Next Post: BA-BE Studies: SOP for Documenting Concomitant Medication Usage – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version